Glaxosmithkline Plc Adr Stock Price History
| GSK Stock | USD 36.17 0.38 1.04% |
Below is the normalized historical share price chart for GlaxoSmithKline PLC ADR extending back to March 28, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlaxoSmithKline PLC stands at 36.17, as last reported on the 16th of February 2025, with the highest price reaching 36.60 and the lowest price hitting 36.16 during the day.
If you're considering investing in GlaxoSmithKline Stock, it is important to understand the factors that can impact its price. As of now, GlaxoSmithKline Stock is very steady. GlaxoSmithKline PLC ADR holds Efficiency (Sharpe) Ratio of 0.0759, which attests that the entity had a 0.0759 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for GlaxoSmithKline PLC ADR, which you can use to evaluate the volatility of the firm. Please check out GlaxoSmithKline PLC's risk adjusted performance of 0.0168, and Market Risk Adjusted Performance of 0.0368 to validate if the risk estimate we provide is consistent with the expected return of 0.13%.
At this time, GlaxoSmithKline PLC's Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.6 B this year, although the value of Common Stock will most likely fall to about 1.3 B. . At this time, GlaxoSmithKline PLC's Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 8.65 this year, although the value of Price Earnings To Growth Ratio will most likely fall to (1.02). GlaxoSmithKline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of July 1986 | 200 Day MA 38.7748 | 50 Day MA 34.4858 | Beta 0.339 |
GlaxoSmithKline |
Sharpe Ratio = 0.0759
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | GSK | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.72 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average GlaxoSmithKline PLC is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding it to a well-diversified portfolio.
Price Book 4.3373 | Enterprise Value Ebitda 10.05 | Price Sales 2.3526 | Shares Float 3.9 B | Dividend Share 0.61 |
GlaxoSmithKline PLC Stock Price History Chart
There are several ways to analyze GlaxoSmithKline Stock price data. The simplest method is using a basic GlaxoSmithKline candlestick price chart, which shows GlaxoSmithKline PLC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 5, 2025 | 37.7 |
| Lowest Price | January 14, 2025 | 32.08 |
GlaxoSmithKline PLC February 16, 2025 Stock Price Synopsis
Various analyses of GlaxoSmithKline PLC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell GlaxoSmithKline Stock. It can be used to describe the percentage change in the price of GlaxoSmithKline PLC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of GlaxoSmithKline Stock.| GlaxoSmithKline PLC Price Action Indicator | (0.40) | |
| GlaxoSmithKline PLC Price Daily Balance Of Power | (0.86) | |
| GlaxoSmithKline PLC Price Rate Of Daily Change | 0.99 |
GlaxoSmithKline PLC February 16, 2025 Stock Price Analysis
GlaxoSmithKline Stock Price History Data
The price series of GlaxoSmithKline PLC for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 has a statistical range of 5.62 with a coefficient of variation of 3.12. Under current investment horizon, the daily prices are spread out with arithmetic mean of 34.43. The median price for the last 90 days is 34.13. The company completed 1226:1000 stock split on 22nd of July 2022. GlaxoSmithKline PLC ADR completed dividends distribution on 2025-02-21.| Open | High | Low | Close | Volume | ||
02/16/2025 | 36.48 | 36.60 | 36.16 | 36.17 | ||
| 02/14/2025 | 36.48 | 36.60 | 36.16 | 36.17 | 4,541,900 | |
| 02/13/2025 | 36.17 | 36.62 | 36.01 | 36.55 | 4,462,003 | |
| 02/12/2025 | 35.72 | 36.26 | 35.53 | 36.13 | 3,619,800 | |
| 02/11/2025 | 36.32 | 36.35 | 35.98 | 36.07 | 4,892,843 | |
| 02/10/2025 | 36.37 | 36.91 | 36.37 | 36.47 | 4,539,234 | |
| 02/07/2025 | 36.49 | 36.52 | 35.97 | 36.04 | 4,945,495 | |
| 02/06/2025 | 37.52 | 37.61 | 36.37 | 36.38 | 6,452,398 | |
| 02/05/2025 | 37.06 | 37.91 | 37.03 | 37.70 | 10,180,917 | |
| 02/04/2025 | 34.59 | 34.98 | 34.22 | 34.84 | 7,121,000 | |
| 02/03/2025 | 34.87 | 35.20 | 34.58 | 34.90 | 3,280,000 | |
| 01/31/2025 | 35.19 | 35.52 | 35.06 | 35.27 | 5,112,700 | |
| 01/30/2025 | 35.07 | 35.59 | 34.92 | 35.36 | 5,020,400 | |
| 01/29/2025 | 34.95 | 35.25 | 34.94 | 35.06 | 6,057,200 | |
| 01/28/2025 | 35.51 | 35.59 | 34.83 | 35.10 | 4,552,900 | |
| 01/27/2025 | 34.83 | 35.50 | 34.83 | 35.50 | 6,505,300 | |
| 01/24/2025 | 34.01 | 34.31 | 33.95 | 34.27 | 3,165,900 | |
| 01/23/2025 | 33.85 | 34.17 | 33.79 | 34.05 | 3,738,400 | |
| 01/22/2025 | 33.64 | 33.73 | 33.41 | 33.43 | 3,546,100 | |
| 01/21/2025 | 33.57 | 33.79 | 33.53 | 33.78 | 4,111,300 | |
| 01/17/2025 | 33.60 | 33.60 | 33.25 | 33.43 | 3,930,400 | |
| 01/16/2025 | 32.82 | 33.51 | 32.72 | 33.44 | 4,534,800 | |
| 01/15/2025 | 32.79 | 32.92 | 32.51 | 32.80 | 4,782,300 | |
| 01/14/2025 | 32.22 | 32.28 | 31.72 | 32.08 | 6,251,200 | |
| 01/13/2025 | 32.74 | 32.86 | 32.55 | 32.70 | 4,673,700 | |
| 01/10/2025 | 33.26 | 33.40 | 33.01 | 33.09 | 3,841,800 | |
| 01/08/2025 | 33.71 | 33.92 | 33.40 | 33.75 | 2,709,100 | |
| 01/07/2025 | 33.97 | 34.46 | 33.97 | 34.09 | 3,031,000 | |
| 01/06/2025 | 33.54 | 34.12 | 33.42 | 33.96 | 3,333,800 | |
| 01/03/2025 | 33.98 | 33.98 | 33.42 | 33.47 | 2,902,300 | |
| 01/02/2025 | 33.94 | 34.19 | 33.84 | 33.95 | 1,999,000 | |
| 12/31/2024 | 33.83 | 34.02 | 33.63 | 33.82 | 2,413,800 | |
| 12/30/2024 | 34.08 | 34.08 | 33.55 | 33.65 | 5,081,300 | |
| 12/27/2024 | 33.97 | 34.17 | 33.87 | 34.08 | 3,174,400 | |
| 12/26/2024 | 34.00 | 34.15 | 33.89 | 34.12 | 1,991,900 | |
| 12/24/2024 | 33.86 | 34.21 | 33.84 | 34.03 | 1,383,078 | |
| 12/23/2024 | 33.86 | 34.11 | 33.63 | 34.06 | 3,228,802 | |
| 12/20/2024 | 33.14 | 33.87 | 33.04 | 33.60 | 6,812,800 | |
| 12/19/2024 | 33.61 | 33.70 | 33.39 | 33.43 | 3,306,300 | |
| 12/18/2024 | 34.10 | 34.34 | 33.69 | 33.69 | 3,075,100 | |
| 12/17/2024 | 34.12 | 34.56 | 34.03 | 34.23 | 4,546,200 | |
| 12/16/2024 | 33.68 | 33.97 | 33.58 | 33.58 | 4,916,600 | |
| 12/13/2024 | 34.02 | 34.08 | 33.75 | 33.95 | 3,391,000 | |
| 12/12/2024 | 34.27 | 34.43 | 34.08 | 34.17 | 3,386,300 | |
| 12/11/2024 | 34.81 | 34.98 | 34.42 | 34.45 | 3,954,100 | |
| 12/10/2024 | 35.89 | 35.90 | 35.18 | 35.21 | 5,383,600 | |
| 12/09/2024 | 34.95 | 36.28 | 34.91 | 35.99 | 7,252,400 | |
| 12/06/2024 | 34.60 | 34.80 | 34.43 | 34.57 | 3,702,700 | |
| 12/05/2024 | 34.42 | 34.56 | 34.21 | 34.53 | 4,509,000 | |
| 12/04/2024 | 34.74 | 34.75 | 34.40 | 34.40 | 4,394,100 | |
| 12/03/2024 | 34.70 | 35.09 | 34.58 | 34.90 | 5,911,000 | |
| 12/02/2024 | 34.23 | 34.33 | 33.97 | 34.31 | 3,144,800 | |
| 11/29/2024 | 34.05 | 34.20 | 33.89 | 34.13 | 2,051,800 | |
| 11/27/2024 | 34.19 | 34.47 | 34.19 | 34.33 | 2,959,000 | |
| 11/26/2024 | 34.23 | 34.29 | 33.85 | 34.02 | 4,194,500 | |
| 11/25/2024 | 34.05 | 34.25 | 34.02 | 34.15 | 4,148,500 | |
| 11/22/2024 | 33.83 | 34.15 | 33.76 | 33.96 | 4,173,100 | |
| 11/21/2024 | 33.40 | 33.70 | 33.17 | 33.70 | 7,030,400 | |
| 11/20/2024 | 33.40 | 33.53 | 33.19 | 33.35 | 7,519,400 | |
| 11/19/2024 | 33.28 | 33.60 | 33.23 | 33.46 | 8,988,100 | |
| 11/18/2024 | 33.29 | 33.79 | 33.25 | 33.69 | 8,802,100 |
About GlaxoSmithKline PLC Stock history
GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.7 B | 5 B | |
| Net Income Applicable To Common Shares | 13.5 B | 14.1 B |
GlaxoSmithKline PLC Stock Technical Analysis
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
GlaxoSmithKline PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for GlaxoSmithKline PLC's price direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0168 | |||
| Jensen Alpha | 0.016 | |||
| Total Risk Alpha | 0.014 | |||
| Sortino Ratio | 0.0113 | |||
| Treynor Ratio | 0.0268 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.167 | Dividend Share 0.61 | Earnings Share 1.55 | Revenue Per Share | Quarterly Revenue Growth 0.008 |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.